Thank you, Angela, for bringing this to our attention!

Teva Pharmaceutical Industries just issued a recall of one lot of its generic Parkinson’s disease combination medication, carbidopa/levodopa, over it potentially containing too much of an active pharmaceutical ingredient.

Teva Pharmaceutical Industries indicated that the recall, which has been deemed a Class II, involved 3,881 bottles of carbidopa/levodopa 25 mg/100 mg, according to FiercePharmaManufacturing. Teva also indicated that stability testing revealed that the recalled carbidopa/levodopa may be what the drug maker described as “super potent.” The voluntary recall is for the entire United States.
According to the U.S. Food and Drug Administration (FDA), the lot number involved is 29C220 and the expiry date is 11/15…

Click here to read the full article.

Click here to read more on the FDA website.